secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ayala Pharmaceuticals, Inc. (—)
CIK:        0001797336
Form:       8-K
Filed at:   2022-11-23T23:59:59+00:00
Accession:  0001193125-22-292007
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Ayala receives Nasdaq delisting notice for MVPHS non-compliance; 180-day cure until May 2023
--------------------------------------------------------------------------------

- Nasdaq notified Ayala on Nov 18, 2022 of non-compliance with minimum $5M MVPHS requirement.
- Trading of AYLA common stock on Nasdaq Global Market is unaffected during the cure period.
- Ayala has until May 17, 2023 to regain compliance; MVPHS must close at $5M+ for 10 consecutive days.
- Possible remedies include transferring to Nasdaq Capital Market or appealing a delisting notice.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1797336/000119312522292007/0001193125-22-292007-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1797336/000119312522292007/d169360d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-292007

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer